Abstract
The blood–brain barrier (BBB) restricts the delivery of many potentially important therapeutic agents for the treatment of brain disorders. An efficient strategy for brain targeted delivery is the utilization of the targeting ligand conjugated nanoparticles to trigger the receptor-mediated transcytosis. In this study, transferrin (Tf) was employed as a brain targeting ligand to functionalize the fluorescein-loaded magnetic nanoparticles (FMNs). The Tf conjugated FMNs (Tf-FMNs) were characterized by transmission electron microscopy, thermal gravimetric analysis, Fourier transform infrared spectroscopy, and X-ray photoelectron spectroscopy. Using fluorescein as an optical probe, the potential of Tf-FMNs as brain targeting drug carriers was explored in vivo. It was demonstrated that Tf-FMNs were able to cross the intact BBB, diffuse into brain neurons, and distribute in the cytoplasm, dendrites, axons, and synapses of neurons. In contrast, magnetic nanoparticles without Tf conjugation cannot cross the BBB efficiently under the same conditions. Therefore, Tf-FMNs hold great potential in serving as an efficient multifunctional platform for the brain-targeted theranostics.
Similar content being viewed by others
References
Chomoucka J, Drbohlavova J, Huska D, Adam V, Kizek R, Hubalek J. Magnetic nanoparticles and targeted drug delivering. Pharmacol Res. 2010;62:144–9.
Kumar A, Jena PK, Behera S, Lockey RF, Mohapatra S, Mohapatra S. Multifunctional magnetic nanoparticles for targeted delivery. Nanomed Nanotechnol Biol Med. 2010;6:64–9.
Pardridge WM. Blood-brain barrier delivery. Drug Discov Today. 2007;12:54–61.
Abbott NJ, Patabendige AAK, Dolman DEM, Yusof SR, Begley DJ. Structure and function of the blood–brain barrier. Neurobiol Dis. 2009;37:13–25.
Li HY, Qian ZM. Transferrin/transferrin receptor-mediated drug delivery. Med Res Rev. 2002;22:225–50.
Visser CC, Stevanovic S, Voorwinden LH, Gaillard PJ, Crommelin DJA, Danhof M, de Boer AG. Validation of the transferrin receptor for drug targeting to brain capillary endothelial cells in vitro. J Drug Target. 2004;12:145–50.
Veiseh O, Sun C, Fang C, Bhattarai N, Gunn J, Kievit F, Du K, Pullar B, Lee D, Ellenbogen RG, Olson J, Zhang MQ. Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood–brain barrier. Cancer Res. 2009;69:6200–7.
Lu CW, Hung Y, Hsiao JK, Yao M, Chung TH, Lin YS, Wu SH, Hsu SC, Liu HM, Mou CY, Yang CS, Huang DM, Chen YC. Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling. Nano Lett. 2007;7:149–54.
Lopez–Lopez MT, Duran JDG, Delgado A, Gonzalez-Caballero F. Stability and magnetic characterization of oleate-covered magnetite ferrofluids in different nonpolar carriers. J Colloid Interface Sci. 2005;291:144–51.
Tsai CP, Chen CY, Hung Y, Chang FH, Mou CY. Monoclonal antibody-functionalized mesoporous silica nanoparticles (MSN) for selective targeting breast cancer cells. J Mater Chem. 2009;19:5737–43.
Santra S, Yang H, Stanley JT, Holloway PH, Moudgil BM, Walter G, Mericle RA. Rapid and effective labeling of brain tissue using TAT-conjugated CdS: Mn/ZnS quantum dots. Chem Commun. 2005;25:3144–6.
Yang S, Chen D, Li N, Mei X, Qi X, Li H, Xu Q, Lu J. A facile preparation of targetable pH-sensitive polymeric nanocarriers with encapsulated magnetic nanoparticles for controlled drug release. J Mater Chem. 2012;22:25354–61.
Liu J, Wang B, Hartono SB, Liu T, Kantharidis P, Middelberg APJ, Lu GQ, He L, Qiao SZ. Magnetic silica spheres with large nanopores for nucleic acid adsorption and cellular uptake. Biomaterials. 2012;33:970–8.
Huang S, Li C, Cheng Z, Fan Y, Yang P, Zhang C, Yang K, Lin J. Magnetic Fe3O4@mesoporous silica composites for drug delivery and bioadsorption. J Colloid Interface Sci. 2012;376:312–21.
Knezevic NZ, Slowing II, Lin VSY. Tuning the release of anticancer drugs from magnetic iron oxide/mesoporous silica core/shell nanoparticles. ChemPlusChem. 2012;77:48–55.
Lin YS, Tseng CT, Hung Y, Chang C, Mou CY. Synthesis of hollow silica nanospheres with a microemulsion as the template. Chem Commun. 2009;3542–3544:3542–4.
De Palma R, Peeters S, Van Bael MJ, Van den Rul H, Bonroy K, Laureyn W, Mullens J, Borghs G, Maes G. Silane ligand exchange to make hydrophobic superparamagnetic nanoparticles water-dispersible. Chem Mater. 2007;19:1821–31.
van Schooneveld MM, Vucic E, Koole R, Zhou Y, Stocks J, Cormode DP, Tang CY, Gordon RE, Nicolay K, Meijerink A, Fayad ZA, Mulder WJM. Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation. Nano Lett. 2008;8:2517–25.
Costantino L, Gandolfi F, Tosi G, Rivasi F, Vandelli MA, Forni F. Peptide-derivatized biodegradable nanoparticles able to cross the blood–brain barrier. J Controlled Release. 2005;108:84–96.
Roberts RL, Fine RE, Sandra A. Receptor-mediated endocytosis of transferrin at the blood–brain barrier. J Cell Sci. 1993;104:521–32.
Beduneau A, Saulnier P, Benoit JP. Active targeting of brain tumors using nanocarriers. Biomaterials. 2007;28:4947–67.
Bickel U, Kang YS, Yoshikawa T, Pardridge WM. In-vivo demonstration of subcellular-localization of antitransferrin receptor monoclonal antibody-colloidal gold conjugate in brain capillary endothelium. J Histochem Cytochem. 1994;42:1493–7.
Acknowledgments
The authors thank the financial supports from Beijing Municipal Education Committee (KM20110025007), Beijing Municipal Foundation for the Talents (2011D005018000001), Natural Science Foundation of China (81271639), and the Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality (PHR201007114).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Feng Yan and Ying Wang have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Yan, F., Wang, Y., He, S. et al. Transferrin-conjugated, fluorescein-loaded magnetic nanoparticles for targeted delivery across the blood–brain barrier. J Mater Sci: Mater Med 24, 2371–2379 (2013). https://doi.org/10.1007/s10856-013-4993-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10856-013-4993-3